Apogee Therapeutics, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2023 Dec2024
Revenue & cost
Revenue -9.02M-34.74M
Gross Profit -9.02M-34.74M
Operating items
Research & Development 68.42M167.87M
Selling, General & Administrative 24.58M49.01M
Operating Expenses 93.00M216.87M
Operating Income -93.00M-216.87M
EBIT -93.00M-216.87M
Non-operating items
Interest & Investment Income 9.02M34.74M
Other Non Operating Income 9.02M34.74M
Non Operating Income 9.02M34.74M
Net income details
EBT -83.98M-182.13M
Tax Provisions 0.02M
Profit After Tax -83.98M-182.15M
Income from Continuing Operations -83.98M-182.15M
Consolidated Net Income -83.98M-182.15M
Income towards Parent Company -83.98M-182.15M
Net Income towards Common Stockholders -83.98M-182.15M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 50.67M58.51M
EBITDA -93.00M-216.87M